In July 2002, the combined (oestrogen and progestogen) HRT arm of the Women's Health Initiative (WHI) trial, a study that was set up to investigate the long-term effects of HRT in healthy post-menopausal women in the USA, was prematurely stopped because a pre-defined threshold of harm was reached.